GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Revvity Inc.
Revvity, formerly known as PerkinElmer, supplies instruments, reagents, and software for scientific research and diagnostics. Its stock price reflects funding in the life sciences, demand for diagnostic tests, and technological innovation in this field.
Share prices of companies in the market segment - Medanalysis
Revvity supplies instruments and reagents for scientific research and diagnostics. We classify it as a medical analysis company. The chart below shows the overall dynamics of this sector, which depends on funding in the life sciences and demand for diagnostic tests.
Broad Market Index - GURU.Markets
Revvity is a global life sciences company providing tools, reagents, and software for diagnostics and scientific research. Its market capitalization earns it a spot in the GURU.Markets index. The chart below shows how its stock performs relative to the broader market.
Change in the price of a company, segment, and market as a whole per day
RVTY - Daily change in the company's share price Revvity Inc.
The daily price change for Revvity, a life sciences solutions provider, demonstrates its sensitivity to pharmaceutical R&D budgets. While the graph of these fluctuations is unspectacular, it is a critical component of formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
Revvity, Inc. is a diversified life sciences and diagnostics company. This chart shows the average daily volatility of the sector. Comparing it to RVTY's performance helps assess whether its broad portfolio of products and services makes it more or less stable than its more specialized competitors.
Daily change in the price of a broad market stock, index - GURU.Markets
Revvity is a global life sciences company providing tools, reagents, and services for diagnostics and research. Its business serves as a barometer of global scientific activity. The chart below illustrates general market fluctuations, which can be used to assess Revvity's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Revvity Inc.
Revvity is a life sciences company providing diagnostic and research tools and solutions. Its year-over-year performance reflects the level of global R&D investment in pharmaceuticals and biotechnology. The chart below tells the story of its role in the scientific world.
Annual dynamics of market capitalization of the market segment - Medanalysis
Revvity, Inc., formerly known as PerkinElmer, is a global life sciences and diagnostics company. Its tools and solutions are used in drug discovery and genetic research. The chart below shows how its focus on these high-tech and growth markets impacts its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Revvity is a life sciences company providing diagnostic and research tools and solutions. Its diversified business serves both pharmaceutical companies and clinical laboratories, providing stability.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Revvity Inc.
Revvity, a provider of tools and services for life science research, is a vital part of the scientific ecosystem. The monthly fluctuations in the chart reflect the R&D budgets of the pharmaceutical and biotech companies that are its primary clients.
Monthly dynamics of market capitalization of the market segment - Medanalysis
This chart reflects the dynamics of the life sciences sector. For Revvity, a diversified giant, this provides context. Its movements reflect stable demand for its diagnostic and scientific instruments, as well as its services for pharmaceutical and biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Revvity is a leading provider of instruments, reagents, and software for biomedical research and diagnostics. Its clients include laboratories, pharmaceutical companies, and biotech companies. Despite the market fluctuations shown in the chart, Revvity's business is more stable, as R&D and diagnostic spending is less cyclical than the overall economy.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Revvity Inc.
Revvity provides tools and services for biomedical research. The company's weekly stock price reflects funding levels in science and biotechnology, as well as overall activity in the pharmaceutical industry. It serves as a barometer of the health of the R&D sector.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Revvity (formerly PerkinElmer) is a life sciences solutions provider. Comparing its weekly performance with the healthcare sector will reveal how the market views its transformation. The chart shows whether the company is outperforming the industry due to its focus on high-growth diagnostics and research markets.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
As a supplier to the life sciences sector, Revvity is sensitive to R&D spending. Comparing its weekly performance with the broader market will reveal how dependent its business is on overall economic health. The chart allows you to assess whether the stock is leading or following the market on the wave of biotech innovation.
Market capitalization of the company, segment and market as a whole
RVTY - Market capitalization of the company Revvity Inc.
Revvity's market capitalization chart reflects long-term trends in the life sciences and diagnostics industries. Formerly known as PerkinElmer, the company focuses on pharmaceutical research and medical diagnostics solutions. Its performance reflects how investors view the robust demand for the tools and reagents that underpin modern biotechnology.
RVTY - Share of the company's market capitalization Revvity Inc. within the market segment - Medanalysis
Revvity provides instruments, reagents, and software for life sciences, diagnostics, and pharmaceuticals. The company's market share reflects its deep integration into scientific and medical workflows worldwide. The chart below illustrates the weight of this important, albeit often overlooked, player in healthcare.
Market capitalization of the market segment - Medanalysis
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. The chart below shows the overall market capitalization of the medical testing sector. It reflects the volume of global investment in science and healthcare, which directly impacts demand for Revvity's products and services.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph shows the value of tools for scientific discovery. Revvity supplies equipment and reagents for biomedical research. Its market capitalization grows along with its spending on science and pharmaceuticals. This visualizes how the R&D business is the foundation for future medical breakthroughs.
Book value capitalization of the company, segment and market as a whole
RVTY - Book value capitalization of the company Revvity Inc.
Revvity's capital comes from its manufacturing facilities for scientific equipment, diagnostic instruments, and reagents. Its book value reflects this sophisticated technological and manufacturing base. The chart below shows how the company, formerly known as PerkinElmer, managed its asset portfolio, focusing on life sciences.
RVTY - Share of the company's book capitalization Revvity Inc. within the market segment - Medanalysis
Revvity provides tools and services for diagnostics and scientific discovery. Its tangible assets include factories producing sophisticated laboratory equipment and reagents, as well as a network of diagnostic laboratories. The chart shows the company's share of the physical infrastructure supporting biomedical research.
Market segment balance sheet capitalization - Medanalysis
Revvity, formerly part of PerkinElmer, provides instruments and services for the life sciences industry. Its business is capital-intensive, requiring ownership of factories to manufacture equipment and reagents. The sector's BCap_Seg chart shows that this industry relies on a complex material base.
Book value of all companies included in the broad market index - GURU.Markets
Revvity's assets comprise a global network of manufacturing sites and laboratories that create instruments and reagents for biomedical research. Its book value reflects its sophisticated scientific and manufacturing infrastructure. The chart below shows the physical weight of this supplier to the entire life sciences industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Revvity Inc.
Revvity's balance sheet is its factories producing scientific equipment and reagents. The premium the market pays reflects its critical role in the life sciences ecosystem, its technologies, and its broad customer base. The chart below shows how the market values this important "science supplier."
Market to book capitalization ratio in a market segment - Medanalysis
Revvity supplies scientific equipment, reagents, and software to laboratories. The company's value lies in its technology, extensive customer base, and recurring revenue from consumables. The chart shows how the market values these factors relative to its manufacturing assets.
Market to book capitalization ratio for the market as a whole
Revvity provides tools and solutions for the life sciences and diagnostics industries. The company has both manufacturing assets and valuable intellectual property. This chart helps understand how the market values the company's combination of assets and innovative potential compared to overall market trends.
Debts of the company, segment and market as a whole
RVTY - Company debts Revvity Inc.
Revvity, a provider of life sciences and diagnostics solutions, uses debt to finance strategic acquisitions and R&D investments. This chart shows how the company leverages its comprehensive portfolio of products and technologies, aiming to become a leader in improving human health and driving scientific discovery.
Market segment debts - Medanalysis
Revvity provides tools and services for biomedical research and diagnostics. This business requires ongoing investment in research and development and the acquisition of new technologies. The company's debt policy reflects its innovation strategy. This chart shows how Revvity uses capital to strengthen its position in a rapidly evolving industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Revvity Inc.
Revvity provides solutions for life sciences research and diagnostics. This business requires ongoing investment in research and development and technology. This chart shows how the company balances debt and equity to fund innovation. This helps assess its financial flexibility and long-term growth strategy.
Market segment debt to market segment book capitalization - Medanalysis
Revvity provides tools and solutions for life sciences research, diagnostics, and pharmaceuticals. Growth in this sector often occurs through acquisitions and R&D investments. The chart shows how the company's leverage strategy compares to overall financial standards and the size of the industry.
Debt to book value of all companies in the market
Revvity, a provider of life sciences solutions, is growing through acquisitions. This chart shows how aggressive its debt M&A strategy is across the economy, comparing the company's debt to the total market capitalization of all market sectors.
P/E of the company, segment and market as a whole
P/E - Revvity Inc.
Revvity (formerly PerkinElmer) is a global company providing instruments, reagents, and software for biomedical research and diagnostics. This chart shows how the market values its research-intensive business. Its performance depends on research funding, demand from pharmaceutical companies, and the success of new diagnostic products.
P/E of the market segment - Medanalysis
Revvity provides tools and solutions for biomedical research, working with leading scientific centers. This chart shows the average rating for the Life Science Tools sector. It allows you to understand how Revvity compares to its competitors, reflecting the demand for scientific equipment and diagnostics.
P/E of the market as a whole
Revvity (formerly PerkinElmer) supplies instruments, reagents, and software for biomedical research and diagnostics. It's a company that equips scientists. This chart reflects general market trends. Revvity's valuation depends on the level of research funding and R&D budgets of pharmaceutical giants, which may not align with short-term sentiment on Wall Street.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Revvity Inc.
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Its estimated price, shown here, is based on research and development budgets in the pharmaceutical and biotech industries, as well as the demand for diagnostic tests.
%20P%2FE%20Revvity%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Revvity-Inc.&v=1772505748895 "Chart of the company's future (projected) P/E Revvity Inc.")
Future (projected) P/E of the market segment - Medanalysis
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. This chart reflects profitability expectations for the sector. It provides an overview of how the market views the company's diversified product portfolio and its role in supporting scientific discovery and the development of new treatments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772505748896 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Revvity, Inc. (formerly part of PerkinElmer) provides products, services, and solutions for the diagnostics, scientific research, and pharmaceutical industries. This chart shows overall investor sentiment. For a company at the intersection of science and healthcare, it demonstrates how the market views the prospects for global investment in scientific research and medical technology.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772505748897 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Revvity Inc.
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. The net financial performance reflected here is driven by research budgets at pharmaceutical companies and academia. The chart shows how investments in science and healthcare translate into revenue for laboratory solution providers.
Profit of companies in the market segment - Medanalysis
Revvity (formerly PerkinElmer) is a scientific company providing instruments, reagents, and software for diagnostics, life sciences, and applied markets. Its products are used in laboratories worldwide. The data in the chart reflects the overall state of the sector, where Revvity's technological solutions accelerate scientific discovery and improve health.
Overall market profit
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Its clients include pharmaceutical companies, laboratories, and research institutes. Demand for Revvity's products reflects the level of investment in science and drug development, which typically rises during periods of overall economic stability, as shown in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Revvity Inc.
Revvity (formerly PerkinElmer) is a global life sciences company providing instruments, reagents, and software for diagnostics and research. The revenue forecast in this chart reflects analyst expectations for demand in the pharmaceutical and biotech industries, as well as diagnostic testing volumes.
%20profit%20of%20the%20company%20Revvity%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Revvity-Inc.&v=1772505748905 "Graph of future (projected) profit of the company Revvity Inc.")
Future (predicted) profit of companies in the market segment - Medanalysis
Revvity provides instruments, reagents, and software for biomedical research, diagnostics, and pharmaceutical development. The company serves the scientific community. This chart shows revenue forecasts for the medical analytics sector, helping to understand how Revvity's broad product portfolio positions it within the growing life sciences industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772505748910 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Demand for its products depends on funding levels for science and healthcare. This curve, reflecting general economic expectations, can influence public and private budgets allocated to scientific research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772505748911 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Revvity Inc.
Revvity (formerly PerkinElmer) supplies instruments, reagents, and software for biomedical research and diagnostics. This chart shows how investors value the company's revenue, a key supplier to the pharmaceutical and scientific industries. The valuation reflects the stability and importance of its products.
P/S market segment - Medanalysis
Revvity, Inc., formerly known as PerkinElmer, provides instruments, reagents, and software for the life sciences, diagnostics, and food industries. The company's revenue is diversified across several knowledge-intensive markets. This chart shows the average valuation for the sector, allowing one to assess how the market values Revvity's technology portfolio.
P/S of the market as a whole
Revvity (formerly PerkinElmer) is a scientific company providing instruments, reagents, and software for diagnostics, life sciences research, and applied markets. It is a diversified healthcare business. This chart helps understand how the market values companies providing critical technologies to the medical and scientific industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Revvity Inc.
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. This chart shows how the market values the company relative to its future sales. It reflects investor expectations for rising global spending on research and development of new drugs and diagnostics.
%20P%2FS%20Revvity%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Revvity-Inc.&v=1772505748914 "The graph of the company's future (projected) P/S Revvity Inc.")
Future (projected) P/S of the market segment - Medanalysis
Revvity provides instruments, reagents, and software for biomedical research, diagnostics, and pharmaceutical development. The company supports scientists and clinicians in their work. This metric reflects how the market perceives its future revenue in the diversified life sciences sector compared to its competitors.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772505748916 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Its clients include pharmaceutical companies, laboratories, and research centers. This chart, reflecting overall optimism, is important to RVTY as an indicator of readiness to invest in R&D. Economic growth allows for greater investment in science and drug development.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772505748917 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Revvity Inc.
This chart illustrates the operations of a diversified life sciences company. For Revvity, it reflects the combined revenues from two key areas: sales of diagnostic tools for early disease detection and the provision of pharmaceutical research and development solutions.
Sales of companies in the market segment - Medanalysis
Revvity, Inc. (formerly part of PerkinElmer) provides products, services, and solutions for diagnostics, life sciences, and applied markets. Sales of its instruments and reagents are dependent on funding for science and healthcare. This chart shows how investments in drug development and genetic research impact Revvity's financial performance.
Overall market sales
Revvity (formerly PerkinElmer) supplies instruments, reagents, and software for scientific research, diagnostics, and pharmaceuticals. Demand for its products reflects the level of investment in science and innovation in the life sciences industry. The company's growth is a leading indicator of future breakthroughs in medicine, the engine of modern economic growth.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Revvity Inc.
Revvity, formerly known as PerkinElmer, supplies instruments, reagents, and software for biomedical research and diagnostics. The company's future sales are dependent on scientific funding, pharmaceutical R&D budgets, and the development of personalized medicine.
%20sales%20of%20the%20company%20Revvity%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Revvity-Inc.&v=1772505748923 "Schedule of future (projected) sales of the company Revvity Inc.")
Future (projected) sales of companies in the market segment - Medanalysis
Revvity, Inc. provides instruments, reagents, and software for biomedical research and diagnostics. The forecast for the medical analytics sector reflects the level of funding for science and healthcare. It shows how scientific breakthroughs and the need for accurate diagnostics are driving demand for the company's products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772505748924 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Demand for its products depends on research funding from governments and private companies. Overall economic activity, reflected here, influences corporate budgets and government appropriations for science, which drives Revvity.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772505748925 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Revvity Inc.
Revvity, a company providing tools and solutions for the life sciences and diagnostics industries, demonstrates the performance of its diversified business in this chart. Profitability depends on sales of reagents, instruments, and software to pharmaceutical companies, laboratories, and diagnostic centers worldwide.
Market segment marginality - Medanalysis
Revvity (formerly PerkinElmer) is a global company providing products, services, and solutions for the diagnostics, scientific research, and pharmaceutical industries. This chart reflects the average profitability in the life sciences sector. A broad technology portfolio and strong market position enable the company to maintain stable and high margins compared to its peers.
Market marginality as a whole
Revvity, Inc. (formerly PerkinElmer) is a global company providing products, services, and solutions in the life sciences and diagnostics industries. This chart shows total revenue. It illustrates Revvity's transformation strategy. The company has shifted its focus to higher-growth, higher-margin segments to improve its long-term profitability.
Employees in the company, segment and market as a whole
Number of employees in the company Revvity Inc.
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Its diversified business requires a significant staff of scientists, engineers, and sales professionals. The dynamics in this graph may reflect both organic growth in key segments and integration following strategic acquisitions.
Share of the company's employees Revvity Inc. within the market segment - Medanalysis
Revvity, formerly part of PerkinElmer, is a global life sciences company providing instruments, reagents, and software for diagnostics and research. This chart shows its scientific footprint. It reflects Revvity's significant share of the scientific, genetic, and engineering workforce in the diagnostics equipment and reagent industry.
Number of employees in the market segment - Medanalysis
Revvity, formerly part of PerkinElmer, is a global life sciences and diagnostics company. This chart illustrates the scale and complexity of the modern biomedical industry. The company employs thousands of scientists and engineers to create tools and solutions that accelerate scientific discovery and improve disease diagnosis.
Number of employees in the market as a whole
Revvity provides instruments, reagents, and software for biomedical research and diagnostics. Demand for its products depends on funding for science and healthcare. Overall economic growth, reflected in employment growth, is driving increased investment in R&D by both the government and private companies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Revvity Inc. (RVTY)
Revvity (formerly part of PerkinElmer) is a life sciences and diagnostics company. This chart shows how the market values its research-intensive business. Its high market capitalization per employee reflects the fact that its team of scientists and engineers creates complex instruments and reagents that are critical for pharmaceutical and research laboratories.
%20of%20the%20company%20Revvity%20Inc.%20(RVTY)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Revvity-Inc.-RVTY&v=1772505748934 "Chart of market capitalization per employee (in thousands of dollars) of the company Revvity Inc. (RVTY)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Revvity is a life sciences and diagnostics solutions company, offering instruments, reagents, and software for laboratories and researchers. This chart shows the industry average cost per employee. It helps assess how the market values Revvity's technology portfolio and its ability to serve the scientific and medical markets per employee.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772505748935 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Revvity (formerly PerkinElmer) supplies instruments, reagents, and software for biomedical research and diagnostics. The company serves scientific laboratories and clinics worldwide. This chart helps assess how the market values a supplier of complex technologies, where expertise and innovation are key value drivers.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772505748936 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Revvity Inc. (RVTY)
Revvity (formerly part of PerkinElmer) is a life sciences company providing instruments, reagents, and software for diagnostics, research, and drug development. It's a high-tech business serving laboratories. This chart shows how productive their innovations are. It measures how much revenue each engineer and scientist generates by equipping the scientific world with tools.
%20Chart%20Revvity%20Inc.%20(RVTY)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Revvity-Inc.-RVTY&v=1772505748938 "Company Profit Per Employee (in thousands of dollars) Chart Revvity Inc. (RVTY)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Revvity (formerly PerkinElmer) is a leader in "laboratory equipment" (life sciences). This chart shows the benchmark for "Med-analysis." The average profit per employee is high here. It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from "blades" (disposable consumables, software), generated by a small staff.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772505748941 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Revvity (formerly part of PerkinElmer) provides instruments, reagents, and software for biomedical research and diagnostics. It is a business serving the science and medical industries. This chart illustrates how supplying high-tech and consumable materials to laboratories worldwide generates a stable revenue stream and high profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772505748942 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Revvity Inc. (RVTY)
Revvity provides tools and services for biomedical research and diagnostics. This chart reflects the value of its science-intensive products. Its high revenue per employee reflects the company's supply of sophisticated equipment and reagents to laboratories worldwide. This reflects the company's investment in technology and innovation.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Revvity-Inc.-RVTY&v=1772505748944 "Sales chart per company employee Revvity Inc. (RVTY)")
Sales per employee in the market segment - Medanalysis
Revvity (formerly part of PerkinElmer) provides solutions for the life sciences and diagnostics industries. They produce instruments, reagents, and laboratory software. This metric reflects how productive their teams (R&D, manufacturing, and sales) are in creating and delivering high-tech solutions to the scientific and medical communities compared to their competitors.
Sales per employee for the market as a whole
Revvity, Inc. (formerly part of PerkinElmer) is a life sciences and diagnostics solutions company, including reagents, instruments, and software. This chart shows how much revenue each employee generates. It reflects the value of their high-tech products to laboratories, research centers, and hospitals, as well as their ability to monetize both equipment and consumables.
Short shares by company, segment and market as a whole
Shares shorted by company Revvity Inc. (RVTY)
Revvity (formerly part of PerkinElmer) provides instruments, reagents, and software for biomedical research and diagnostics. The company serves pharmaceutical companies and laboratories. This chart shows bearish sentiment. Bears can expect cuts in R&D budgets in the biotech sector following the post-pandemic boom.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Revvity-Inc.-RVTY&v=1772505748947 "Short Shares Chart for the Company Revvity Inc. (RVTY)")
Shares shorted by market segment - Medanalysis
Revvity (formerly part of PerkinElmer) provides solutions for the life sciences and diagnostics industries, including reagents and laboratory tools. This chart shows overall short positions in the Life Sciences Tools sector. If it's high, investors expect R&D budgets in biotech and pharma to shrink, which will reduce demand for equipment and consumables.
Shares shorted by the overall market
Revvity (RVTY) (formerly PerkinElmer) is a supplier of scientific instruments, reagents, and software for biotech and diagnostic laboratories. This chart shows the overall level of fear. As pessimism rises, investors worry: will biotech and pharmaceutical companies freeze their R&D budgets, which will hurt demand for RVTY equipment?
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Revvity Inc. (RVTY)
Revvity (formerly PerkinElmer) is a science supplier. They sell lab instruments, reagents, and software to biotech and pharmaceutical companies. **This chart** measures momentum. A strong report showing rising R&D budgets at their biotech clients could trigger a rally that would push **This chart** into overbought territory (above 70).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Revvity-Inc.-RVTY&v=1772505748957 "RSI 14 indicator chart for the company's stock Revvity Inc. (RVTY)")
RSI 14 Market Segment - Medanalysis
Revvity (RVTY), formerly PerkinElmer, is a "shovel supplier" for the life sciences. They sell instruments, reagents, and software for laboratories (R&D, diagnostics). This metric measures the "temperature" of the sector. It helps us understand: is RVTY oversold due to a decline in R&D budgets in biotech or is there a general cooling in the sector as a whole?
RSI 14 for the overall market
Revvity (RVTY), formerly part of PerkinElmer, specializes in life sciences and diagnostics solutions. They provide research and analysis tools. This market climate graph is important. Research and development (R&D) budgets are cyclical. During periods of euphoria, pharmaceutical companies and labs spend heavily, but during times of panic, R&D spending is often cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RVTY (Revvity Inc.)
Revvity (formerly part of PerkinElmer) is a life sciences company. They provide reagents, instruments, and software for diagnostics and biotech research. This chart shows the average 12-month target from analysts. It reflects their expectations for pharmaceutical R&D budgets and demand for diagnostic equipment.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RVTY-Revvity-Inc.&v=1772505748960 "A chart showing analyst consensus forecasts for the expected stock price. RVTY (Revvity Inc.)")
The difference between the consensus estimate and the actual stock price RVTY (Revvity Inc.)
Revvity (formerly part of PerkinElmer) is a life sciences and diagnostics company. They provide instruments, reagents, and software for pharmaceutical research and clinical laboratories. This chart shows analyst estimates of biopharma R&D spending and diagnostics demand. It reflects the gap between the target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RVTY-Revvity-Inc.&v=1772505748961 "A chart showing the difference between the consensus forecast and the actual stock price. RVTY (Revvity Inc.)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Revvity (formerly part of PerkinElmer) is a company serving science. It supplies consumables, instruments, and software to laboratories engaged in pharmaceutical R&D and clinical diagnostics. This chart shows general expectations for the medical testing sector. It reflects whether experts believe R&D budgets will grow globally.
Analysts' consensus forecast for the overall market share price
Revvity is a former PerkinElmer division focused on life sciences. They produce instruments and reagents for diagnostics and R&D. Market expectations, as shown in this graph, influence the R&D budgets of pharmaceutical and biotech companies, their primary clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Revvity Inc.
Revvity (formerly part of PerkinElmer) is a life sciences and diagnostics company. They supply laboratory instruments, reagents, and software, specializing in genetic screening (including newborn screening) and biotechnology research. This chart reflects the stable demand for their consumables and diagnostic tests.
AKIMA Market Segment Index - Medanalysis
Revvity (formerly PerkinElmer) is the unseen champion of the life sciences; the company supplies high-tech equipment (devices, consumables) for laboratories (diagnostics, drug R&D). This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does Revvity's indispensable role in scientific research distinguish it from the average competitor?
The AKIM Index for the overall market
Revvity, formerly PerkinElmer, is a leading provider of life science instruments, supplying equipment and reagents for biotechnology and diagnostics. This chart, reflecting the market average, provides context. It helps assess how Revvity, whose business relies on R&D budgets in defense sectors, fits within the overall macroeconomic picture.
